Renaissance Capital logo

Movano Priced, Nasdaq: MOVE

Developing a wearable device that measures glucose, blood pressure, and heart rate.

Industry: Health Care

Latest Trade: $1.80 0.00 (0.0%)

First Day Return: +32.0%

Return from IPO: -64.0%

Industry: Health Care

We are a health-focused technology company developing simple, smart and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. We are developing a proprietary platform that uses Radio Frequency ("RF") technology, which we believe will enable the creation of low-cost and scalable sensors that are small enough to fit into a wearable, and other small form factors. We expect that our platform will provide users with the ability to measure and continuously monitor vital health data and provide actionable feedback to jumpstart changes in behaviors. Our platform is the foundation for our first product in development, which is a non-invasive and cuffless wearable that simultaneously measures glucose, blood pressure and heart rate. It is intended to combine the functionality of a continuous glucose monitor ("CGM") and a cuffless RF-based blood pressure monitor ("rBPM") into one wearable device. Once developed, we believe it will allow users to manage their health with confidence and in a manner that best fits their lifestyle, ultimately improving health outcomes.
more less
IPO News for Movano
more
IPO Data
IPO File Date 02/02/2021
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 8.5
Deal Size ($mm) $43
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/22/2021
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 8.5
Deal Size ($mm) $43
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Pleasanton, CA
Founded 2018
Employees 15
Website www.movano.com